AVANIR PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/231009ab-42a4-4239-b582-61288b7c6a4a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-46.3M | 2013-10-01 – 2014-09-30 | evidence 0001193125-14-439125 |
| FY 2013 | $-71.4M | 2012-10-01 – 2013-09-30 | evidence 0001193125-14-439125 |
| FY 2012 | $-58.4M | 2011-10-01 – 2012-09-30 | evidence 0001193125-14-439125 |
| FY 2011 | $-60.6M | 2010-10-01 – 2011-09-30 | evidence 0001193125-11-339193 |
| FY 2010 | $-27.1M | 2009-10-01 – 2010-09-30 | evidence 0001193125-11-339193 |
| FY 2009 | $-21.9M | 2008-10-01 – 2009-09-30 | evidence 0001193125-11-339193 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AVANIR PHARMACEUTICALS, INC. — all facts · Revenue · Net Income